In GSE107231, the expression of RPL35, RPS3A, and RPS8 was significantly decreased in NAFLD livers compared to the healthy controls (Supplementary Figure 4). The gene discussed is RPS3A; the disease is metabolic dysfunction-associated steatotic liver disease.